Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
WE

W. Mark Eickhoff — 17 Patents

Merck: 7 patents #1,614 of 9,382Top 20%
NLNano Systems L.L.C.: 6 patents #1 of 47Top 3%
Eastman Kodak: 2 patents #3,607 of 8,114Top 45%
EIElan Pharma International: 1 patents #50 of 111Top 50%
Lansdale, PA: #76 of 839 inventorsTop 10%
Pennsylvania: #4,187 of 74,527 inventorsTop 6%
Overall (All Time): #263,971 of 4,157,543Top 7%
17 Patents All Time
W. Mark Eickhoff has been granted 17 US patents while listed as an inventor at Nano Systems L.L.C.. The first was granted in 1995 and the most recent in November 2025. W. Mark Eickhoff ranks #263,971 of 4,157,543 US inventors in our database (top 6.3%). Patent records list W. Mark Eickhoff in Lansdale, PA, US.

Patents per Year

Patents granted per year, 1995 to 2025Bar chart with a peak of 6 patents in 1996.peak 61995: 1 patents19951996: 6 patents19961997: 2 patents19972002: 1 patents20022018: 1 patents20182024: 2 patents20242025: 4 patents2025

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12458633 Treatment of migraine Mary K Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2025-11-04
12458632 Treatment of migraine Mary K Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2025-11-04
12310953 Pharmaceutical formulations for the treatment of migraine Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2025-05-27
12220408 Treatment of migraine Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2025-02-11
12168004 Treatment of migraine Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2024-12-17 $757,929,000
11925709 Tablet formulation for CGRP active compounds Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2024-03-12 $345,937,000
10117836 Tablet formulation for CGRP active compounds Mary Ann Johnson, Leonardo R. Allain, Craig B. Ikeda, Chad D. Brown, Francis J. Flanagan, JR. +6 more 2018-11-06 $409,859,000
6432381 Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract Gary Liversidge, Kathleen J. Illig, Pramod Sarpotdar, Stephen B. Ruddy 2002-08-13
5628981 Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents Gary Liversidge, Kathleen J. Illig, Pramod Sarpotdar, Stephen B. Ruddy 1997-05-13
5593657 Barium salt formulations stabilized by non-ionic and anionic stabilizers Stephen B. Ruddy, Gary Liversidge, Mary E. Roberts 1997-01-14
5585108 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays Stephen B. Ruddy, Gary Liversidge, Eugene R. Cooper 1996-12-17
5580579 Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers Stephen B. Ruddy, Gary Liversidge 1996-12-03
5571536 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids Karl Mueller, David A. Engers 1996-11-05
5560931 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids Karl Mueller, David A. Engers 1996-10-01
5518738 Nanoparticulate nsaid compositions David A. Engers, Karl Mueller 1996-05-21
5503723 Isolation of ultra small particles Stephen B. Ruddy 1996-04-02 $14,865,000
5466440 Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays Stephen B. Ruddy, Gary Liversidge, Eugene R. Cooper 1995-11-14 $5,715,000